- €2.60bn
- €3.08bn
- $3.84bn
- 71
- 74
- 34
- 65
Annual balance sheet for Glanbia, fiscal year end - January 4th, USD millions except per share, conversion factor applied.
2021 January 2nd | R2022 December 31st | R2022 January 1st | 2023 December 30th | 2025 January 4th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 201 | 468 | 262 | 414 | 417 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 372 | 398 | 417 | 492 | 383 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,053 | 1,655 | 1,619 | 1,483 | 1,487 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 640 | 612 | 663 | 603 | 606 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3,743 | 4,117 | 4,109 | 3,799 | 3,875 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 878 | 1,195 | 1,005 | 881 | 1,055 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,775 | 2,133 | 2,147 | 1,667 | 1,802 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,968 | 1,984 | 1,962 | 2,133 | 2,073 |
Total Liabilities & Shareholders' Equity | 3,743 | 4,117 | 4,109 | 3,799 | 3,875 |
Total Common Shares Outstanding |